Our clinical trial intelligence is deployed on the the global cell and gene therapy (CGT) pipeline to identify where clinical trial friction is constraining commercial value.

Using Panoptic Bio’s AI-driven Probability of Success framework, it benchmarks leading programs from companies such as Pfizer, Johnson & Johnson, and Bayer across major disease domains including Oncology, Hematology, and CNS.